https://doi.org/10.1016/j.vaccine.2024.126586
G
Gagandeep Singh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
64
Citations
5
h-index
2
i10-index
Gagandeep Singh is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Influenza Virus Research Studies & COVID-19 Clinical Research Studies. The author has an h-index of 5, co-authored 15 publications.
Papers by this author
worksA single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge
2024 · Vaccine · 4 citations
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge
2024 · Vaccine · 4 citations
https://doi.org/10.1016/j.vaccine.2024.126586
Portable UV-C device to treat high flow of infectious aerosols generated during clinical respiratory care
2024 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-024-82901-x
Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice
2025 · Vaccine · 2 citations
https://doi.org/10.1016/j.vaccine.2025.126825
Portable UV-C Device to Treat High Flow of Infectious Aerosols Generated during Clinical Respiratory Care
2024 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-4648863/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat